For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
Both President Trump and Democratic presidential candidates are pushing for Medicare reforms. One approach improves Medicare the other eliminates it.
President Trump's decision to mandate immigrants have health coverage is appropriate, and his Proclamation may actually give immigrants access to affordable coverage.
Democrats want to impose price controls on prescription drugs, even though Medicare's long history of price controls shows that they don't control spending.
House Speaker Nancy Pelosi (D-Calif.) formally released her long-awaited drug-pricing bill last week, and very few individuals and organizations endorsed it outright.
Trump’s motivation combined with some degree of real agreement on policy issues suggest that lawmakers could find a way to craft legislation aimed at controlling drug prices. But there are still plenty of reasons to think the effort will go nowhere.
House Speaker Nancy Pelosi’s drug pricing scheme slaps government price controls on Medicare Parts B and D, financially punishes any drug manufacturer that cannot accept the government-imposed price, and puts Washington’s financial interests before the well-being of actual patients.
Can patients act like consumers in the health care marketplace? Liberals say no, conservatives, and new evidence, say yes.
A new IPI publication says the revived effort to legalize the importation of prescription drugs has bipartisan support, but the practice remains just as dangerous as ever, since the lawmakers who hope to benefit from the scheme’s political expediency simply cannot guarantee the safety of imported drugs.
Importing prescription drugs from Canada or other countries is no safer today than it was more than a decade ago.Importation proponents used to say “show us the bodies” of people harmed by importation. Sadly, today we can.
Important distinction: The right to see any doctor doesn't mean the right to see a doctor soon.